Sertoli cells isolated from the testis (referred to as extratesticular Sertoli cells) have been shown to facilitate allo-and xenogeneic cell transplantations. It appears likely that the ability of these cells to enhance the success of cell engraftment is due, in part, to the retention of their intratesticular functions of trophic support and immunoprotection. Sertoli cells also are involved in the regulation of angiogenesis in the testis, which may also contribute to enhanced cell engraftment success facilitated by extratesticular Sertoli cells. Because the maintenance of the cell's intratesticular angiogenic function has not yet been evaluated for extratesticular Sertoli cells, this study examined the cell's ability to enhance angiogenesis in vitro. Sertoli cell conditioned media were derived from isolated rat Sertoli cell cultures and used in a rat aortic model of induced angiogenesis, in endothelial and smooth muscle cell monocultures, and in endothelial smooth muscle cocultures. An angiogenic rat cytokine array identified angiogenic factors in the control and conditioned media. Aorta sections incubated with Sertoli cell conditioned media showed a marked increase in the formation of capillary-like structures when compared to controls. Likewise, endothelial cells incubated in conditioned media organized into capillary-like structures not observed when incubated in control media. In coculture, smooth muscle cells were associated with endothelial cell-derived capillary-like structures only when incubated in conditioned media. Cytokine arrays indicated the presence and a qualitative increase of specific angiogenic growth factors in Sertoli cell conditioned media not observed in control media. Results indicate that extratesticular Sertoli cells retain their intratesticular angiogenic function in vitro.
INTRODUCTION
vessels (angiogenesis) remains fundamental to healing, growth, and survival of cells and tissues (8, 37) . Extensive research over the last 35 years related to tumor The success of therapeutic cell and tissue transplantation depends on a variety of criteria, all of which must growth, arthritis (58) , and retinopathy (41) has characterized chemical factors involved in new vessel forma-be optimized to ensure a meaningful therapeutic outcome. Immune rejection is the main cause of transplan-tion and has shown a variety of ways to induce angiogenesis to revascularize damaged tissue, or to inhibit tation failure (5, 24) , although recent advances in transplantation medicine have lowered the incidence rate of angiogenesis in the case of malignant tumor growth (26, 33, 59, 60, 64) . acute graft rejection (10). Typically, transplantation success relies on aggressive and chronic immunosuppres-Recently, efforts in angiogenic research have been directed toward the use of stem cells and cell therapeutics sion, exposing the individual to serious and potentially life-threatening consequences. If rejection does not oc- (37) . Repair of severely damaged organs and/or damaged systems have been attempted with the use of cell cur immediately, successful engraftment occurs only if the cells or tissues are completely and adequately vascu-therapies such as cell transplantation (19, 26, 28, 31, 46) . One approach to increasing the survival and efficacy of larized. If cells are not within 150-200 µm of a blood supply to receive nutrients and eliminate waste, they will cell transplants is by enhancing the revascularization of the cell graft by improving the angiogenic process of ex-become ischemic (8), enhancing the rejection cascade even in the presence of systemic immunosuppression isting blood vessels through the use of angiogenic growth factors. Stimulation or enhancement of angiogenesis (3, 21) .
The formation of new blood vessels from preexisting during tissue modification and expansion requires the 1136 GOLAT AND CAMERON involvement of multiple growth factors such as vascular to enhance the viability and immunoprotection of grafted cells and tissues (9, 13, 14) . Because Sertoli cells also se-endothelial growth factor (VEGF) (25, 34, 37, 39, 40, 45, 50) , basic fibroblast growth factor (bFGF) (4, 30, 31, 67) , crete angiogenic factors (13,23), it is possible that SC ET retain this functional ability and stimulate neovasculari-platelet-derived growth factor (PDGF) (40) , insulin-like growth factor-1 (IGF-1) (40), fractalkine (9,63), and tu-zation of newly transplanted cells and tissues, thereby enhancing graft survival and transplantation protocol mor necrosing factor-α (TNF-α) (1, 29, 32, 67) . Increasing the amounts of these types of growth factors at the efficacy.
In this study we hypothesize that SC ET will increase graft site greatly improves the chances for survival of grafted cells and tissues (28) . The delivery of a vector capillary-like microvascular proliferation in vitro. This will be tested utilizing a modified version of the rat aorta encoded with a single growth factor or a growth factor recombinant protein (28) , primarily VEGF (38), into is-model of induced angiogenesis (41,43), and endothelia and smooth muscle mono-and cocultures incubated in chemic sites in hopes of promoting new vessel growth has yet to show clinical efficacy (25) , indicating that a Sertoli cell preconditioned media. Sertoli cell secreted factors will be identified by angiogenic cytokine micro-multifactorial pharmacological protocol is likely to be of a more productive therapeutic value. Previous cell-based array. attempts to elicit new vessel growth include the injection MATERIALS AND METHODS of endothelial progenitor cells (27, 33, 61, 67) , bone mar-Sertoli Cell Isolation, Pretreatment, and Conditioning row-derived stem cells (62), or peripheral blood progenof Media itor cells (2, 34) directly into ischemic areas.
For more than 10 years, Sertoli cells isolated from As previously described (6) , decapsulated rat testes the testis [referred to as extratesticular Sertoli cells were subjected to sequential enzymatic treatment at (SC ET )] have been used to enhance the successful en-37°C using 0.25% trypsin (Sigma) and 0.1% collagenase graftment of both allo-and xenogeneic cells and tissues (Sigma, type V). The resulting Sertoli cell aggregates in the peripheral and central nervous systems in experiwere plated in T150 cell culture flasks (Costar) in a volmental cell transplantation therapies for clinical disorume of approximately 50 ml of maintenance media ders such as Parkinson's disease, type 1 diabetes, and (MM), which consisted of either DMEM/F12 (DEM/ Huntington's disease (16) (17) (18) (19) 48, 54, 56) . Sertoli cells ex-F12, Mediatech, Inc) supplemented with retinol (50 ng/ press many trophic factors, regulatory proteins, and numl), ITS+ (1000 µl/100 ml), antibiotics, antimycotics, tritive factors that aid in the modeling of the testis durand gentamycin or endothelial basal media (EBM, ing embryonic development (21,44,45,57) and nourish Sigma) supplemented with antibiotics, antimycotics, and and stimulate the growth and development of germ cells gentamycin. Plated Sertoli cell aggregates then were in- (23) . Sertoli cells become terminally differentiated at cubated at 39°C in 5% CO 2 /95% air for 48 h, after which puberty and thereafter function in the adult testis to prothe cultures were subjected to hypotonic treatment with vide a favorable environment for germ cell viability and sterile 0.5 mM Tris-HCl buffer for 1 min to expedite the differentiation, and to protect these highly antigentic removal of contaminating germ cells. maturing cells against immune detection and rejection.
Following three washes, cell culture flasks were re-Even after isolation, Sertoli cells retain the ability to seplenished with 50 ml of maintenance media (MM) and crete trophic, immune, and growth factors (7) , which returned to the CO 2 injected 37°C incubator. The resulthave been shown to enhance the survival and differentiing pretreated Sertoli cell-enriched cultures contained ation of cocultured neurons (51,52,65,66) and islets (13, greater than 97% Sertoli cells. Sertoli cell cultures then 14) and are presumed to do so in vivo when cotransplanwere incubated for 48 h at 37°C to allow for secretion ted with cells and tissues (17, 19, 53, 55) . Angiogenic facof growth and trophic factors into the maintenance metors and proteins that Sertoli cells are known to secrete dia. These media were pipetted from the culture flasks, include VEGF, IGF-1, bFGF, transforming growth faccentrifuged to remove cells and cellular debris, identitor-α (TGF-α) and TGF-β, PDGF, neurturin, interleufied as Sertoli cell-enriched media (SCM), and immedikin-1α (IL-1α), IL-6, and tissue inhibiting matrix metalately stored at −80°C for later use. loproteinase-1 (TIMP-1) (11, 29, 47) . Sertoli cells also Aortic Ring Bioassay produce lactate (3,12), pyruvate (3), putrescine (46), and glutathione (24) , which also have been shown to be in-Preparation of the bioassay was modified from a previously reported rat angiogenesis assay (41). Thoracic volved in angiogenesis. Although the mechanisms by which SC ET promote successful cell and tissue engraft-aortas were surgically removed from adult female Sprague-Dawley rats under aseptic conditions as ap-ment are not yet fully defined, it appears likely that the delivery of multiple growth, trophic, and immune sup-proved by institutional guidelines and placed in sterile MM where peri-adventitial fibroadipose tissue was re-pressive factors at the graft site accounts for their ability moved. The "cleaned" aorta was washed in MM (4×) each placed in a 35-mm culture dish. One was incubated in experimental SCM and the other with control MM. and cut into 1-2-mm-thick sections also under sterile conditions. After excision, aortic sections were placed in Following incubation, the membranes were processed for the detection of angiogenic factors with a HRP-the wells of a 24-well culture plate (Nunc) on 200 µl solidified growth factor reduced Matrigel TM (MG RF , BD substrate conjugate as per the manufacturer's instructions. Biosciences), covered with an additional 100 µl MG RF , and placed in a 37°C incubator for 5-7 min. This re-RESULTS sulted in the aortic rings being embedded in roughly the middle of a three-dimensional MG RF matrix. The MG RF -Results were the same regardless of whether the SCM (experimental media) and the MM (control media) were embedded aortic rings were covered with 1 ml of experimental SCM or control MM and returned to the 37°C composed of either DMEM/F12 or EBM. incubator. Substrate utilized in all aortic ring cultures Aortic Ring Bioassay was from the same lot of MG RF to negate any differences in biological composition. As an additional control, aor-Capillary-like structures were visualized arising first from the MG RF -embedded aortic rings as early as 2 days tic rings were prepared without substrate. Digital photomicrographs of aortic rings in vitro were taken following when incubated in SCM, whereas aortic rings incubated in MM did not show capillary-like formation until ap-24-h incubation and then daily for the following 5 days utilizing differential interference contrast (DIC) optics. proximately 4 days of incubation. By 5 days of incubation there was a marked qualitative increase in the for-Tubulogenesis Assay mation of capillary-like structures from MG RF -embedded Bovine aortic endothelial cells (BAE, Cell Applicaaortic rings incubated in SCM when compared to rings tions) were prelabeled with DiO Cell Tracker (green) incubated in MM ( Fig. 1 ). Although the preponderance immunofluorescent marker (Molecular Probes), and boof capillary-like growth was observed on the external vine aortic smooth muscle cells (BASM, Cell Applicasurface of the aortic ring, some growth was observed tions) were prelabeled with DiI Cell Tracker (red) imoriginating from its internal (luminal) surface ( Fig. 1 ). munofluorescent marker (Molecular Probes) as per the Cultures in which aortic rings were not embedded in manufacturer's instructions. Cells were then plated at MG RF resulted in unobservable growth of capillary-like the density of 20,000 cells/well in mono-or cocultures structures regardless of which media were utilized. in MG RF -coated 96-well culture plates in a total volume of 100 µl SCM or MM. Cocultures of BAE and BASM Morphology were plated at a 1:1 ratio. All cultures were incubated at
The morphology of capillary-like structures extend-37°C and 5% CO 2 /95% air for up to 5 days and microing from aortas incubated in SCM exhibited an exscopically evaluated at 24 h postplating and daily therepanded branching pattern distally (Figs. 1 and 2) when after. As controls, mono-and cocultures were plated in compared to similar structures extending from aortic 96-well plates without the MG RF substrate.
rings incubated in MM. Evaluation of aortic ring thick sections revealed a consistent structural difference be-Morphology tween those incubated in SCM compared to those incu-Aortic rings and mono-and cocultures were visualized bated in MM. Aortic rings incubated in SCM displayed directly by DIC optics and/or by reflected fluorescence a simple squamous layer of cells, external to a thick on an Olympus IX71/IX51 inverted research microscope. layer of extracellular material, which was contiguous Mono-and cocultures examined by fluorescence microsaround the aortic ring by 4 days incubation and consiscopy were visualized through either a FITC or TRITC tent in morphology with a tunica adventitia (Fig. 3B ). filter to detect either DiO or DiI prelabeled cells, respec-Aortic rings incubated in MM displayed similar periphtively. For sectional morphology, aortic rings and were eral extracellular material but lacked the well-organized fixed with 5% gluteraldehyde/PBS for 2 h, washed (3×) simple squamous layer of cells peripherally (Fig. 3A) as with PBS, postfixed with 1% osmium/water, and rouobserved in all the experimental cultures. This external tinely processed into plastic resin. The plastic blocks layer of squamous cells appeared to be the progenitor of were thick sectioned (0.5 µm), stained with toluidine the capillary-like structures newly formed in vitro ( Fig.  blue, and visualized by light microscopy on the Olym-3C) and it was not observed in aortic rings incubated in pus microscope. All images were capture digitally with the absence of MG RF . an Olympus DP-70 camera.
Tubulogenesis Assay Angiogenic Factor Assay
Two dot blot membranes (RayBiotech Inc.) preem-When incubated in SCM, DiO prelabeled bovine endothelial cells (BAE) organized into linear, distinct cap-bedded with angiogenic factor antibodies ( Fig. 5) were illary-like structures and presented as extensive interconnecting structural networks by 48 h, which were more expansive by 96 h of incubation (Fig. 4B ). When incubated in MM, BAE cells formed only a few blunted capillary-like structures and interconnecting network organizations were not apparent (Fig. 4A) .
DiI prelabeled bovine smooth muscle cells (BASM) in monoculture remained unorganized following 96 h of incubation in either SCM or MM (Fig. 4Ci ). When in coculture with BAE cells, however, BASM cells were observer at the periphery of some capillary-like structures formed by the prelabeled BAE when incubated in SCM (Figs. 4C, Cii). This was not observed when the cocultured cells were incubated in MM.
Angiogenic Cytokine Antibody Array
Angiogenic factors in control MM and experimental SCM were identified by signal dot size and density in angiogenic cytokine array membranes. Qualitative evaluation of the membranes indicated that signal dots for vascular endothelial growth factor (VEGF), TIMP-1, monocyte chemoattractant protein-1 (MCP-1), and fractalkine were more prominent in the Sertoli cell-enriched media when compared to membranes incubated in the control media ( Fig. 5 ). migration of endothelia cells to form tubular assemblies, medium indicate that the observed angiogenic responses in vitro were mediated by angiogenic cytokines secreted which then assemble into mature blood vessels (21). The process of angiogensis has been studied in the male re-by isolated Sertoli cells and included VEGF, TIMP-1, MCP-1, and fractalkine. productive system (36) and it is well established that angiogenic cytokines, such as VEGF (68) and a number VEGF is the most studied and characterized angiogenic cytokine. In addition to coordinating endothelial of other growth and trophic factors, are present in the testis and are secreted by intratesticular Sertoli cells cell and pericyte interactions (25) , it regulates blood vessel size during formation (37) . Upregulation of VEGF (23). In the testis, Sertoli cell-secreted angiogenic cytokines help to maintain functional capillaries and are in-in the presence of aortic wall vessels begins a series of event cascades that result in angiogenic sprouting (15). volved in the remodeling of testicular capillary beds (68) .
DISCUSSION
This increase in VEGF can be endogenous, being produced by endothelial cells in response to mechanical and Results of this study indicate that rat Sertoli cells isolated from the testis (SC ET ) in vitro retain their ability to physiological damage to the vessel (39) , as is the case in vivo (35) . It is not unexpected, then, that sectioned secrete growth factors associated with angiogenesis and that these media-soluble factors are capable of eliciting aortic rings could give rise to new endothelial cells and subsequently new capillary-like structures in vitro as an increased microvascular angiogenic response in both excised vascular tissue and endothelial cell mono-and was observed in this study when incubated in the control medium. Also, as demonstrated in this study, it was not cocultures. This demonstrated angiogenic function of SC ET is consistent with the role of intratesticular SCs unexpected that the addition of experimental Sertoli cell medium containing SC-secreted VEGF, and the other to affect the testicular microvascularture, mediated by angiogenic cytokines such as VEGF (68) . Results of the angiogenic factors, greatly enhanced this angiogenic process as has been described for exogenous VEGF and angiogenic cytokine antibody array assay of Sertoli cell illustrated in several cell therapies for treatment of is-served angiogenic responses was not investigated, it is clear that the cocktail of SC-secreted angiogenic factors chemic animal models (2) . Likewise, it is not surprising that the angiogenic factor-rich SCM, but not the control had a marked effect on the de novo formation of capillary-like structures in vitro. MM, stimulated the reorganization of endothelial cells into capillary-like structures in both monoculture and As with VEGF, basal levels of the angiogenic factor TIMP-1 protein have been shown to be secreted by Ser-coculture with smooth muscle cells. Although the precise roles of angiogenic factors in mediating the ob-toli cells in vivo (61) . The secretion levels of TIMP-1 are controlled both systemically, by FSH, and by local kine assay indicated that a large quantity of fractalkine was present in the Sertoli cell medium; however, pres-regulatory controls, indicating TIMP-1's physiological importance in testicular development (61) . In the current ently there is no relevant description for its chemical expression and function within the testis. The age of the study, the Sertoli cells utilized were isolated from prepubertal rats between 16 and 18 days old, a time during testis used for this study was 14-16 days, an age that signifies a vast amount of structural remodeling in the which testicular development is associated with elevated follicle stimulating hormone (FSH). As an inhibitor of testis that may account for the large amount of fractalkine identified. angiogenesis, high amounts of TIMP-1 secretion by Sertoli cells regulate the excessive proliferative effects of MCP-1 has been indicated to have a direct effect on human endothelial cell angiogenesis in vitro (49), but its the stimulatory regulators during extracellular matrix (ECM) degradation (61) . This ability of TIMP-1 to help expression in Sertoli cells prior to this report has only been demonstrated in response to inflammatory cyto-maintain homeostasis of angiogenesis regulators by reducing the potential for uncontrolled vascular growth kines. Its secretion by SC ET in vitro and its role in inducing or enhancing angiogenesis and tubulogenesis, like through excessive ECM degradation and/or vascular proliferation may contribute to the efficacy of using the other SC-secreted angiogenic factors identified in this study, should be further studied before well-SC ET to help regulate microvascular growth in recipients receiving cell transplants facilitated by cotransplantation supported conclusions can be determined.
The question of what aortic ring cell type proliferates with SC ET (19) .
Fractalkine (CX3CL1) is a novel angiogenic chemo-to give rise to capillary-like structures in vitro has not yet been clearly defined. Results of the endothelial kine (63) and a chemoattractant expressed by endothelial cells in response to TNF-α and IGF-1, two cytokines smooth muscle cell cocultures incubated in Sertoli cell medium indicate that, at least in this assay, bovine secreted by Sertoli cells. Results of the angiogenic cyto- 
